Filing Details
- Accession Number:
- 0001600620-24-000022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-22 16:35:13
- Reporting Period:
- 2024-02-20
- Accepted Time:
- 2024-02-22 16:35:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1600620 | Aurinia Pharmaceuticals Inc. | AUPH | Pharmaceutical Preparations (2834) | 981231763 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754122 | Volker Knappertz | #140, 14315-118 Avenue Edmonton A0 T5L 4S6 | Evp, Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-02-20 | 25,146 | $5.48 | 324,058 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.
- Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 shares of common stock were acquired on May 31, 2023 and 2,430 shares of common stock were acquired on November 30, 2023.